COMMUNIQUÉS West-GlobeNewswire

Genmab Announces European Regulatory Submission for Daratumumab in Combination with Lenalidomide and Dexamethasone in Frontline Multiple Myeloma
22/03/2019
Company Announcement Type II variation application submitted to the EMA for daratumumab in combination with lenalidomide and dexamethasone as treatment for newly diagnosed multiple myeloma patients who are not [...]
Exactus Applauds CVS’s Decision to Sell CBD Products
22/03/2019
Exactus Inc. Anticipates Many More National Drugstores to Follow Suit DELRAY BEACH, Fla., March 22, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB:EXDI / OTCQB:EXDID) , a healthcare company pursuing opportunities in Hemp [...]
Crown Bioscience présentera les dernières avancées en matière de plateformes précliniques et translationnelles à au congrès annuel de l'AACR 2019
22/03/2019
15 affiches présenteront les données des nouveaux modèles d'évaluation des nouveaux traitements du cancer SAN DIEGO, 22 mars 2019 (GLOBE NEWSWIRE) -- Crown Bioscience, une société mondiale de services de recherche et de [...]
Herantis Pharma Plc: Change in the number of shares and voting rights
22/03/2019
Herantis Pharma Plc: Change in the number of shares and voting rights Herantis Pharma Plc Company release 22 March 2019 at 10:00 am Herantis Pharma Plc (''Herantis'' or the ''Company'') announced a directed share issue [...]
Oncology Venture has established bridge loan facility
22/03/2019
Press release Hørsholm, Denmark and Cambridge, MA, US, March 22, 2019 – Oncology Venture A/S announced today that its share has received observation status by Nasdaq Stockholm AB, following the publication of its Annual [...]
RAMSAY GENERALE DE SANTE : lancement d'une augmentation de capital
22/03/2019
COMMUNIQUE DE PRESSE Ramsay Générale de Santé annonce le lancement d'une augmentation de capital avec maintien du droit préférentiel de souscription de 625 millions d'euros environ dans le cadre du refinancement de l' [...]
Financial Statement Bulletin
22/03/2019
BBS-Bioactive Bone Substitutes Plc Company Announcement March 22, 2019 at 9:00 am BBS-Bioactive Bone Substitutes Plc (BBS) Interim Report 1.1.-30.6.2018 (unaudited) January-June shortly (comparison season 1-6/2017) The [...]
Novartis plans for Alcon spin-off on April 9, 2019
22/03/2019
Alcon obtained approval for listing on SIX Swiss Exchange and New York Stock Exchange Alcon will seek effectiveness of Form 20-F registration statement from the US Securities and Exchange Commission Alcon will enter key [...]
UCB SA/NV: Convening Notice to attend the general meeting of shareholders to be held at Bluepoint Brussels
22/03/2019
*** Unofficial English translation – For convenience purposes only *** UCB SA/NV - Public Limited Liability Company Allée de la Recherche 60, 1070 Brussels Enterprise nr. 0403.053.608 (RLE Brussels) (" UCB SA/NV " or [...]
UCB SA : Convocation à l'assemblée générale des actionnaires qui se tiendra à Bluepoint Brussels
22/03/2019
UCB - société anonyme Allée de la Recherche 60, 1070 Bruxelles n° d’entreprise 0403.053.608 (RPM Bruxelles) (« UCB SA » ou la « Société ») CONVOCATION À L’ASSEMBLÉE GÉNÉRALE DES ACTIONNAIRES QUI SE TIENDRA À BLUEPOINT [...]
Immutep Announces United States Patent Grant for Eftilagimod Alpha in Cancer
21/03/2019
SYDNEY, Australia, March 21, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]
Osmotica Pharmaceuticals plc to Provide Fourth Quarter and Full Year 2018 Business and Financial Update on March 27, 2019
21/03/2019
BRIDGEWATER, N.J., March 21, 2019 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (“Osmotica” or the “Company”) (Nasdaq: OSMT), a fully integrated biopharmaceutical company, today announced that the Company will [...]
Canada House Wellness Group Builds on Sales License, Closes Oversubscribed $3.3 Million Unit Financing
21/03/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, March 21, 2019 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE: CHV) (“ Canada House ” or the “ Company ”) is [...]
CV Sciences, Inc. Appoints Joerg Grasser as New Chief Financial Officer
21/03/2019
LAS VEGAS, March 21, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp CBD products through its industry- [...]
Humanigen Data Presented at the 2019 National Comprehensive Cancer Network (NCCN) Annual Conference Demonstrates Potential to Improve the Efficacy of CAR-T Therapy
21/03/2019
Enhanced anti-tumor activity, improved overall survival, and improved durability of response with a reduced rate of relapse observed with GM-CSF neutralization Lenzilumab (an anti-GM-CSF monoclonal antibody) used in [...]
Protech Home Medical Announces Date and Time for Quarterly Conference Call
21/03/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, March 21, 2019 (GLOBE NEWSWIRE) -- Protech Home [...]
EDAP TMS SA : EDAP TMS SA to Announce Fourth Quarter and Fiscal Year 2018 Financial Results on Monday, April 1, 2019
21/03/2019
Company to host conference call and webcast on Tuesday, April 2 at 8:30am EDT LYON, France, March 21, 2019 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release [...]
Translate Bio Announces Fourth Quarter and Full Year 2018 Financial Results and Reviews Recent Highlights
21/03/2019
LEXINGTON, Mass., March 21, 2019 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat [...]
Altimmune to Announce Year End 2018 Financial Results on April 2
21/03/2019
GAITHERSBURG, Md., March 21, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced that it will announce financial results for the year ended December 31, [...]

Pages